Evaluating the Impact of Primary Tumor Resection on EGFR-TKI-treated Patients with Advanced Lung Cancer: A Multicenter Propensity-matched Study
Background: Nonsmall-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations is exceptionally sensitive to EGFR tyrosine kinase inhibitors (TKIs). Despite this, disease progression commonly occurs at the primary site, prompting debate on the potential advantages of incorporat...
Saved in:
Main Authors: | Eva Yu-Hsuan Chuang, Chiao-En Wu, Tzu-Wei Kuo, Yu-Wen Wen, Ping-Chih Hsu, Chih-Hsi Scott Kuo, Cheng-Ta Yang, Ling-Jen Hung, Yin-Kai Chao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
Series: | Journal of Cancer Research and Practice |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-24-00037 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failure
by: Zong-Han Yao, et al.
Published: (2025-08-01) -
Successful salvage surgery followed by second ALK–TKI after alectinib failure in a patient with ALK-positive NSCLC
by: Hiroshi Hashimoto, et al.
Published: (2022-04-01) -
The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer
by: Faris Alrumaihi, et al.
Published: (2025-06-01) -
The mechanisms of acquired resistance to anti-EGFR drugs in non-small cell lung cancer not associated with T790m mutation and their significance in clinical practice
by: E. V. Karabina, et al.
Published: (2018-11-01) -
Repeated Anatomical Pulmonary Resection for Second Primary Nonsmall‐Cell Lung Cancer: Safety and Short‐Term Outcomes
by: Céline Forster, et al.
Published: (2025-06-01)